All articles tagged: Sexually transmitted chlamydial infection of other sites (A56.8)

A chlamydia vaccine in early trials shows promise, offering hope for combating the prevalent sexually transmitted infection. The vaccine demonstrated effectiveness and safety in its initial testing phase. Further research is needed to assess its long-term efficacy and potential for widespread use.

The CDC reports a rise in sexually transmitted infection rates among older adults. Factors like lack of awareness, less condom use, and increased sexual activity contribute to the trend. Health experts emphasize the importance of education and regular STI testing for all age groups.

The article reports that syphilis rates in the U.S. are the highest since 1950, with stagnant STD rates despite efforts to control them. The increase in syphilis cases is a concerning public health issue.

For Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline postexposure prophylaxis (PEP) compared with standard care, according to a study published in the Dec. 21 issue of the New England Journal of Medicine.Jenell Stewart, D

From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.Ya-Lin A. Huang, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estim

The FDA approved the first at-home test for chlamydia and gonorrhea, a significant step in addressing rising STI rates in the U.S. However, concerns about increased regulation potentially affecting availability and cost, and the test's limitations in covering all needs, particularly for syphilis and in the gay and bisexual community, remain points of debate.

On Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA

The first new antibiotic for gonorrhea -- the second most common sexually transmitted disease -- has shown promise in a clinical trial.This new antibiotic, called zoliflodacin, was seen in the trial to cure uncomplicated gonorrhea infection as effectively as the current go-to treatment -- ceftriaxone along with one dose of azithromycin pills.

Skin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the Journal of the European Academy of Dermatology and Venereology.Paolo Gisondi, M.D., from the University of Verona in Italy, and colleagues evaluated the burden of the most common dermatological diseases